Approval for a manufacturing site located at invivoscribe technologies, inc. , 10222 barnes canyon rd. , bldg. 1, san diego, california.
Device | LeukoStrat CDx FLT3 Mutation Assay |
Classification Name | Somatic Gene Mutation Detection System |
Generic Name | Somatic Gene Mutation Detection System |
Applicant | INVIVOSCRIBE TECHNOLOGIES, INC |
Date Received | 2018-04-12 |
Decision Date | 2018-12-07 |
PMA | P160040 |
Supplement | S003 |
Product Code | OWD |
Docket Number | Premarket Approval (PMA) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Links U.S. Food & Drug Administration Follow FDA En Español Search FDA Home Food Drugs Medical Devices Radia |
Advisory Committee | Pathology |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Location Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | INVIVOSCRIBE TECHNOLOGIES, INC 6330 Nancy Ridge Drive suite 106 san Diego, CA 92121 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P160040 | | Original Filing |
S010 |
2022-03-15 |
30-day Notice |
S009 |
2021-07-12 |
30-day Notice |
S008 |
2021-07-09 |
Special (immediate Track) |
S007 | | |
S006 |
2019-10-17 |
Normal 180 Day Track |
S005 | | |
S004 |
2018-11-06 |
Real-time Process |
S003 |
2018-04-12 |
Normal 180 Day Track No User Fee |
S002 |
2018-03-30 |
Normal 180 Day Track |
S001 |
2017-12-22 |
30-day Notice |
NIH GUDID Devices